| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $235,803,002 ) (Continued on the next page) |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | K23DK136928 | Developing a Self-Management Intervention to Improve Health Outcomes for Patients with Inflammatory Bowel Disease | 000 | 1 | NIH | 4/3/2024 | $194,000 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01CA282200 | Aberration Correction for Histotripsy Ablation of Liver | 000 | 1 | NIH | 4/24/2024 | $559,105 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01CA290780 | Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer. | 000 | 1 | NIH | 4/2/2024 | $681,198 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R21AI180278 | Defining a novel protein network for Toxoplasma repurposing of host ESCRT machinery | 001 | 1 | NIH | 3/1/2024 | $175,500 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R21AI180278 | Defining a novel protein network for Toxoplasma repurposing of host ESCRT machinery | 001 | 1 | NIH | 3/1/2024 | -$175,500 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | U01AI181882 | University of Michigan MHWFAC CoFar CMC Center Application | 000 | 1 | NIH | 3/15/2024 | $380,000 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R21AI180278 | Defining a novel protein network for Toxoplasma repurposing of host ESCRT machinery | 000 | 1 | NIH | 1/4/2024 | $175,500 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01CA289013 | Orally active CBP/p300 degraders | 000 | 1 | NIH | 3/1/2024 | $688,392 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01CA288526 | MS4A7 in tumor resistance to immunotherapy | 000 | 1 | NIH | 3/1/2024 | $651,124 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F32GM154404 | Sulfide-regulated copper metabolism | 001 | 1 | NIH | 4/2/2024 | $0 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F32GM154404 | Sulfide-regulated copper metabolism | 000 | 1 | NIH | 4/2/2024 | $69,500 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01DK137806 | Human iPSC intestine mimetics with integrated mesenchymal, endothelial and enteric nervous tissue | 000 | 1 | NIH | 2/19/2024 | $542,726 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31GM151823 | Advancing drug discovery for protein domains containing intrinsically disordered regions | 001 | 1 | NIH | 4/3/2024 | $0 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31GM151823 | Advancing drug discovery for protein domains containing intrinsically disordered regions | 000 | 1 | NIH | 4/3/2024 | $40,819 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01HL172832 | Metaboloepigenetics and Atherosclerosis | 000 | 1 | NIH | 2/29/2024 | $560,366 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01CA285790 | Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy | 000 | 1 | NIH | 2/5/2024 | $529,077 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | K23DA059484 | Optimizing an App-based Intervention for Sexual Minoritized Emerging Adults to Reduce Cannabis and Alcohol Co-use | 000 | 1 | NIH | 4/25/2024 | $196,176 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R03CA280126 | Genetically engineered mouse models to investigate the liposarcoma microenvironment | 000 | 1 | NIH | 4/23/2024 | $78,000 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31ES036421 | Disentangling the Drivers and Dangers of Toxic Cyanobacteria Biosynthetic Heterogeneity in Cyanobacterial Harmful Algal Blooms | 001 | 1 | NIH | 3/15/2024 | $0 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31ES036421 | Disentangling the Drivers and Dangers of Toxic Cyanobacteria Biosynthetic Heterogeneity in Cyanobacterial Harmful Algal Blooms | 000 | 1 | NIH | 3/15/2024 | $40,772 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R34AR082551 | Planning for a Multisite Efficacy Trial of Upper Extremity Telerehabilitation for Systemic Sclerosis | 000 | 1 | NIH | 2/16/2024 | $274,560 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R03NS137487 | Developing a Diurnal Rodent Model for Smith-Magenis Syndrome | 000 | 1 | NIH | 4/1/2024 | $170,499 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F99NS124176 | Brain hedonic circuitry mediating 'liking' and 'wanting' for reward (Administrative Supplement/Funded Extension) | 002 | 2 | NIH | 2/28/2024 | $31,207 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | K01DK135799 | Schwann cell-derived extracellular vesicles maintain peripheral nerve function under homeostatic conditions and promote damage in type 2 diabetes, independent of myelination | 000 | 1 | NIH | 12/22/2023 | $139,622 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R25MH136652 | Summer Training Program in Integrative Methods for Mental and Physical Health | 000 | 5 | NIH | 3/13/2024 | $216,643 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01CA278898 | A framework for integrating MR imaging and clinical tests for prediction of outcomes in multiple myeloma treatment | 000 | 1 | NIH | 11/21/2023 | $577,373 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R35GM153209 | Biology and Biochemistry of the Microtubule Cytoskeleton | 000 | 1 | NIH | 3/27/2024 | $243,063 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31NS135973 | Single-cell optical phenotyping for diffuse gliomas using artificial intelligence and label-free microscopy | 000 | 1 | NIH | 12/22/2023 | $40,819 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31NS135973 | Single-cell optical phenotyping for diffuse gliomas using artificial intelligence and label-free microscopy | 001 | 1 | NIH | 12/22/2023 | $0 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R00AG075145 | Older Adults Living with Dementia and Their Informal Caregivers: Reciprocal Impacts of Caregiving and Serious Illness on Health Care Outcomes | 001 | 3 | NIH | 3/14/2024 | $24,898 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R13DC021894 | Mechanics of Hearing Workshop - 2024 | 000 | 1 | NIH | 3/4/2024 | $59,500 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R00AG075145 | Older Adults Living with Dementia and Their Informal Caregivers: Reciprocal Impacts of Caregiving and Serious Illness on Health Care Outcomes | 000 | 3 | NIH | 3/8/2024 | $224,078 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01AR083343 | Extracellular Matrix Regulation of Inflammatory Signaling in Tendon | 000 | 1 | NIH | 4/5/2024 | $343,200 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31AR084289 | Piezo1-driven Synovial Fibrosis in Post-Traumatic Osteoarthritis | 000 | 1 | NIH | 4/5/2024 | $42,897 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | UM1HL172695 | Pediatric Heart Network University of Michigan | 000 | 1 | NIH | 1/22/2024 | $438,748 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R34MH133057 | Facilitating effective coping to reduce suicide risk following ED discharge: A micro-randomized trial to develop an adaptive text-based intervention | 000 | 1 | NIH | 3/20/2024 | $234,000 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01CA279746 | Urology practice consolidation and care for men with prostate cancer | 000 | 1 | NIH | 2/1/2024 | $593,112 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R21AI180617 | Q223R Leptin Receptor Polymorphism in Bacterial Pneumonia | 000 | 1 | NIH | 11/30/2023 | $210,600 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01EY035016 | Determining optimal vision care for emotionally distressed patients with inherited retinal diseases | 000 | 1 | NIH | 2/16/2024 | $595,936 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01EY035016 | Determining optimal vision care for emotionally distressed patients with inherited retinal diseases | 000 | 1 | NIH | 2/16/2024 | $100,000 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R35GM152128 | Coordinated Spatial Organization in Bacteria | 000 | 1 | NIH | 1/22/2024 | $381,935 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | T32TR004764 | CTSA Postdoctoral T32 at the University of Michigan | 000 | 1 | NIH | 11/30/2023 | $418,400 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01HL168369 | Optimization of Cu(II)-ligand catalysts, membrane materials, and coatings for O2-tolerant, portable, and low-cost electrochemical nitric oxide generation devices/catheters | 000 | 1 | NIH | 1/31/2024 | $433,491 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R01AR082325 | Heterogeneous pathways to bone strength decline and hip fracture | 000 | 1 | NIH | 4/11/2024 | $635,789 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R21EB034344 | Novel methods for dynamic MRI of gastrointestinal motor function | 001 | 1 | NIH | 1/23/2024 | $0 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31HL172674 | Defining the metabolic regulation of erythropoiesis | 000 | 1 | NIH | 2/1/2024 | $40,814 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R21EB034344 | Novel methods for dynamic MRI of gastrointestinal motor function | 000 | 1 | NIH | 1/11/2024 | $175,500 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | F31HL172674 | Defining the metabolic regulation of erythropoiesis | 001 | 1 | NIH | 2/1/2024 | $0 |
| | 2024 | 2024 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 1109 GEDDES AVE, SUITE 3300 | ANN ARBOR | MI | 48109-1079 | WASHTENAW | USA | R25TR004776 | MICHR-Translational Science Immersion (MICHR-TSI) | 000 | 1 | NIH | 11/28/2023 | $108,000 |
|
